Detalhe da pesquisa
1.
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
Haematologica
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981812
2.
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes.
Mod Pathol
; 35(9): 1212-1219, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504958
3.
Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
Mod Pathol
; 35(11): 1677-1683, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690645
4.
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Mod Pathol
; 35(4): 470-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775472
5.
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.
Mod Pathol
; 33(9): 1678-1689, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238878
6.
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.
BMC Cancer
; 20(1): 83, 2020 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005111
7.
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
Br J Haematol
; 185(5): 852-864, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924136
8.
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients.
Br J Haematol
; 187(3): 307-318, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243771
9.
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
Mod Pathol
; 32(11): 1698-1707, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231128
10.
Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia.
Haematologica
; 104(2): 305-311, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171025
11.
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Am J Hematol
; 94(7): 757-766, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963592
12.
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.
Ann Diagn Pathol
; 41: 38-42, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132650
13.
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
Cancer
; 124(13): 2704-2713, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682723
14.
Physician interpretation of genomic test results and treatment selection.
Cancer
; 124(5): 966-972, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29165790
15.
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome.
Mod Pathol
; 31(7): 1141-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449681
16.
DDX41 mutations in patients with non-myeloid hematologic neoplasms.
Am J Hematol
; 98(8): E193-E196, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154083
17.
Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
Cancer
; 123(8): 1372-1381, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27911979
18.
Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.
Mod Pathol
; 30(4): 499-508, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28084342
19.
Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Mod Pathol
; 35(5): 705, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903824
20.
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib.
Blood
; 126(6): 790-7, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124496